BTK and mantle cell lymphoma: It has been demonstrated though that MCL-cell lines rely either on the canonical (BCR-BTK‐NF-kB) or non-canonical (MAP3K14‐NF-kB) NF-kB pathways and may develop ibrutinib resistance.